News and Events
Hatchtech completes treatment phase of 2b clinical trial of new-generation headlice treatment DeOvo™
31/08/2011 | Press Releases
Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2 clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.